Category Archives: Biotech Stocks

Indian Equity Market Update – 04Feb2020

Mumbai, 04 Feb 2020. Key equity benchmarks on NSE and BSE ended with robust gains today, supported by steep slide in crude oil prices and positive global shares – after the sharp sell off on Budget Day on Saturday, 01 Feb 2020.

Nifty50 index gained 271 points to 11,979.
BSE Sensex gained 917 points to 40,789.

Market breadth was tilted towards buyers. On the BSE, 1564 shares rose and 856 shares fell. In Nifty 50 index, 45 stocks advanced while 5 stocks declined. Fitch Ratings on Monday said India is expected to clock a GDP growth of 5.6% in the next financial year, as Budget 2020 has not “materially altered” its view on the country’s growth outlook.

The Economic Survey of India released by the government last week projected India’s growth rate at 6-6.5% for FY21. NMDC (up 6.16%), Jindal Steel & Power (up 5.35%), Hindustan Copper (up 4.61%), Hindalco Industries (up 4.24%), SAIL (up 4.02%), Tata Steel (up 3.65%), Vedanta (up 3.24%), JSW Steel (up 2.74%), National Aluminium Company (up 2.04%) and Hindustan Zinc (up 1.93%) advanced. Titan Company jumped 7.59% to Rs 1276.

Reliance Industries gained 2.86% to Rs 1425. L&T advanced 0.56% to Rs 1293.95. Bajaj Auto slipped 4.09% to Rs 3155. TCS was up 0.18% to Rs 2107. Honeywell Automation jumped 14.40% to Rs 31785. PNB fell 1.05% to Rs 56.75. Shriram Transport Finance Company surged 6.58% to Rs 1051.65. Sun Pharmaceuticals advanced 2.06% to Rs 426.10. GlaxoSmithKline Pharmaceuticals crashed 11.71% to Rs 1454.60.

In the US data on the manufacturing sector from the Institute for Supply Management, the purchasing manager’s index rose to a six-month high of 50.9% in January. Media reports showed that OPEC members are planning an emergency meeting for discussing large production cut. The outbreak of the Coronavirus and China’s efforts to stop the spread mean the economy will grow slower this quarter than first thought, according to economists.

Bonus Trade: Buy Glenmark Pharma for Target 919

Here is a bonus trade for our regular website visitors. Buy Glenmark Pharma (NSE:GLENMARK) stock at current market price (INR) 829, for target 919, and 789 as Stop Loss. This stock is listed on NSE and BSE in India. This trade can give 10% gain, and is likely to play out in the coming 4-5 weeks. Following are the trade details.
——————————————————————
Date: 01 May 2016
Stock: Glenmark Pharma (NSE:GLENMARK)
Buy at: 829
Target: 919
Stop: 789
——————————————————————
There should be significant resistance/selling pressure between 919 and 959. Above 959 closing, the stock becomes a fresh buy for higher targets. Continue reading Bonus Trade: Buy Glenmark Pharma for Target 919

Buy Sun Pharma For Target 888

Sun Pharma has taken support at 820-840 level for the third time in recent months. Upside levels should get tested now. CMP 846, Target 888.  Higher targets may also come, but those are for another trade. Below 800, Sun Pharma can move down to 720 level. Therefore, we need to very cautious in any long position below 800. sun-pharma-stock-chart-analysis-11sep2015l, so we need to be very cautious on long trades below 820.